The expression levels of HLA‐G on the surface of NSCLC cells were significantly enhanced after treatment with Atezolizumab or cocultured with PBMCs in the presence of Atezolizumab (Figure 1G,I). Here, HLA-G is linked to non-small cell lung carcinoma.